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Nanoparticle elasticity directs tumor uptake
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To date, the role of elasticity in drug delivery remains elusive due to the inability to measure
microscale mechanics and alter rheology without affecting chemistry. Herein, we describe the
in vitro cellular uptake and in vivo tumor uptake of nanolipogels (NLGs). NLGs are composed
of identical lipid bilayers encapsulating an alginate core, with tunable elasticity. The elasticity
of NLGs was evaluated by atomic force microscopy, which demonstrated that they exhibit
Young’s moduli ranging from 45± 9 to 19,000± 5 kPa. Neoplastic and non-neoplastic cells
exhibited signiﬁcantly greater uptake of soft NLGs (Young’s modulus <1.6 MPa) relative to
their elastic counterparts (Young’s modulus >13.8 MPa). In an orthotopic breast tumor
model, soft NLGs accumulated signiﬁcantly more in tumors, whereas elastic NLGs pre-
ferentially accumulated in the liver. Our ﬁndings demonstrate that particle elasticity directs
tumor accumulation, suggesting that it may be a design parameter to enhance tumor delivery
efﬁciency.
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Nanoliposomes (NLPs) and nanoparticles (NPs) are twomajor classes of drug delivery systems used to controldrug distribution and release1. These two systems may be
engineered with identical size, shape, and surface charge; how-
ever, there exists between them characteristic differences in their
architecture and particle elasticity. NLPs have an aqueous core
encapsulated within a lipid bilayer, whereas NPs are solid struc-
tures composed of amorphous and/or crystalline polymers or
inorganic materials. Both NLPs and NPs exhibit size-dependent
properties, signiﬁcantly different from the properties of the bulk
material.
Physical cues are known to govern cell–NP interactions2,3. One
hundred nanometer particles more efﬁciently avoid the mono-
nuclear phagocyte system (MPS), resulting in prolonged blood
circulation2,4,5. Geometric shape regulates hemorheological
dynamics, cellular uptake, and in vivo fate of NPs6–8. The particle
aspect ratio exhibits up to ten times longer blood circulation than
their spherical counterparts in rodents7. Surface charge also
affects NP circulation lifetime and biodistribution9. Cationic
particles showed signiﬁcantly higher serum protein absorption
and non-speciﬁc uptake by most cell lines compared to neutral or
anionic particles10. Nonetheless, NPs engineered with optimal
size, shape, and surface charge are limited to less than 1% tumor
accumulation11.
Particle elasticity is hypothesized to alter cellular uptake and
tumor accumulation due to its ability to bind cell surface recep-
tors and squeeze through pores12–19. However, the ability to
measure and tune NP elasticity while maintaining uniform size,
shape, and surface chemistry has remained a challenge. Particle
elasticity is often modulated by the extent of crosslinking however
the surface properties (e.g., porosity and chemistry) also change.
There is no mechanistic understanding of how particle elasticity
governs cellular uptake. The results obtained from prior studies
fail to address tumor accumulation. Today, particle elasticity is
not yet a design parameter to enhance tumor delivery efﬁciency.
Herein, we synthesize a hybrid nanolipogel (NLG), an alginate
encapsulating liposome, having a deﬁned size, shape, and surface
charge, with tunable elasticity. NLGs are a model system to
investigate the effect of particle elasticity on both in vitro cellular
uptake and in vivo tumor uptake. This study identiﬁes the
underlying mechanism that governs particle elasticity-mediated
cellular uptake. We further provide the ﬁrst experimental evi-
dence regarding how particle elasticity regulates tumor uptake of
NLGs in an orthotopic tumor model.
Results
Synthesis and characterization of NLGs with varying elasticity.
NLGs feature a core-shell structure with a lipid bilayer shell and a
hydrogel core (Fig. 1a). The elasticity is modulated by the extent
of crosslinking of the “core” material. Alginate undergoes coa-
cervation, and its crosslinking degree is in a function of calcium
concentration. The “shell”, or lipid bilayer, is consistent across all
NLGs and controls the size of NLGs via extrusion method20–22.
DOPC was chosen because it is zwitterionic and in the liquid
phase at 37 °C. The rationale for using this model is to modulate
particle elasticity independent of other physical cues (e.g., particle
size, shape, and surface properties).
Size was characterized by dynamic light scattering (DLS)
(Table 1). All NLP and NLGs exhibited similar hydrodynamic
diameters of ~160 nm. The polydispersity indexes (PDIs) of these
vehicles were less than 0.3, demonstrating uniformity. The zeta-
potentials were slightly negatively charged. The interior structure
was characterized by transmission electron microscopy (TEM).
As seen in Fig. 1b, spherical NPs were formed. The presence of
hollow lipid bilayers in NLPs (with an aqueous core) and a dense
hydrogel core in NLGs are apparent.
The Young’s modulus was determined by atomic force
microscopy (AFM) (Fig. 1c). Particle elasticity correlates with
calcium concentration. The NLPs without hydrogel core show the
lowest Young’s modulus of 45± 9 kPa (NLP-45KPa). Uncros-
slinked NLG (NLG-1.6MPa) and crosslinked NLGs (NLG-
5.3MPa, NLG-13.8MPa, and NLG-19MPa) exhibited Young’s
moduli ranging from 1.6± 0.6 MPa to 19± 5MPa, ~40–400 folds
higher than the elasticity of NLP, respectively. Altogether, NLG
elasticity may be modulated independent of particle size, shape,
and surface charge.
The encapsulation efﬁciency (EE) of FITC-dextran and
scrambled siRNA were studied as two model drugs. As shown
in Fig. 1d and e, all NLGs demonstrated signiﬁcantly higher EEs
of both FITC-Dextran and siRNA than NLP-45KPa. No
signiﬁcant change of EEs was measured among NLGs regardless
of calcium concentration. This may be due to the polysaccharide
network conﬁning the Brownian diffusion of macromolecules
causing retention within the lipid bilayer. The sustained release
proﬁles demonstrated a slowed release of payload as a function of
increasing particle modulus (Fig. 1f). Calcium crosslinking
reduces the pore size of the hydrogel network and, in turn,
affects release. These ﬁndings indicate that a polymeric core
increases EE whereby the extent of crosslinking modulates
release.
Particle elasticity regulates in vitro cellular uptake. The cellular
uptake of NLP-45KPa and NLGs by human breast cancer cells
(MDA-MB-231 and MCF7) and normal human mammary epi-
thelial cells (MCF10A) was studied. NLP-45KPa and NLGs,
labeled with Oregon Green 488-1,2-Dihexadecanoyl-sn-Glycero-
3-Phosphoethanolamine (OG488-DHPE, a ﬂuorescent lipophilic
dye, Ex/Em: ~496/524 nm), exhibited decreasing cellular uptake
with increasing of the modulus, independent of cell type
(Fig. 2a–c). The maximal cellular uptake occurred with NLP-
45KPa (Young’s modulus, 45± 9 kPa), which is consistently 80%
greater than NLG-19MPa. No cytotoxicity was observed across all
samples (Fig. 2d–f). The cellular uptake and toxicity effects were
consistent in murine breast cancer 4T1 cells (Supplementary
Fig. 1).
We further evaluated the inﬂuence of particle concentration
(Fig. 2g), serum (Fig. 2h), and incubation time (Supplementary
Fig. 2) on particle elasticity-mediated cellular uptake. Although
the baseline cellular uptake changed with varying test conditions,
the elasticity dependent trend for uptake was independent of
particle concentration, serum or incubation time.
Fluorescent microscope images (Fig. 2i) conﬁrmed that particle
elasticity modulates cellular uptake. As seen in the ﬂuorescent
images of MDA-MB-231 cells treated with NLP-45KPa, inter-
nalization was high and uniformly dispersed in the cytoplasm. In
contrast, when treated with NLG-19MPa, signiﬁcantly fewer
NLG-19MPa particles were internalized and localized in the
perinuclear region, indicating that they were trapped in
endosomes or lysosomes as a result of endocytosis. This particle
internalization pattern shift with increasing particle elasticity was
also observed in MCF7 cells (Supplementary Fig. 3).
There are two possible explanations for this cell internalization
pattern shift. First, NLPs could enter the cell via different
pathways (e.g., fusion) other than endocytosis. Second, endocy-
tosed NLP could exhibit faster release within the cytoplasm than
elastic NLGs. Previous studies have revealed that the lipid bilayer
of NLPs can readily fuse with the plasma membrane of cells; this
fusion process requires less time and energy than endocytosis23–
25. We therefore hypothesized that particle elasticity may mediate
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cellular uptake by regulating cell internalization pathways. In our
hypothesis, as illustrated in Fig. 3, soft NLP-45KPa may enter the
cell through two independent pathways: fusion and endocytosis.
Fusion is more dominant than endocytosis due to its low-energy
requirement26. In comparison, the elastic NLGs may enter the cell
only through endocytosis, which necessitates membrane bending,
surface tension, and coated pits; thus, cells take more time and
energy to internalize the same amount of NLG-19MPa as
opposed to NLP-45KPa.
To validate this hypothesis, three endocytosis inhibitors
(Filipin, Chlorpromazine, and Dynasore) were used to inhibit
caveolae-mediated, clathrin-mediated, and caveolae/clathrin-
mediated endocytosis, respectively. Cellular uptake of NLP-
45KPa was not affected by any of the endocytosis inhibitors
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Fig. 1 Synthesis and characterization of NLP and NLGs with varying elasticity. a Schematic illustration of nanoliposome–hydrogel complex system. NLP
represents nanoliposome encapsulating PBS. Uncrosslinked NLG represents nanoliposome encapsulating uncrosslinked alginate (0mM CaCl2).
Crosslinked NLG represents nanolipogel encapsulating 1–5mM CaCl2 crosslinked alginate. b The internal structure of NLP-45KPa, NLG-1.6MPa, and NLG-
19MPa characterized by TEM. Scale bars represent 100 nm. c The Young’s moduli of synthesized NLP and NLGs characterized by AFM. The encapsulation
efﬁciencies of FITC-dextran (d) and siRNA (e) in synthesized NLP and NLGs. f Sustained release proﬁles of synthesized FITC-dextran encapsulating NLP
and NLGs. *P< 0.05, **P< 0.01, ***P< 0.001. The mean values and error bars are deﬁned as mean and S.D., respectively
Table 1 Dynamic light scattering characterization of synthesized NLP and NLGs with varying elasticity
Sample Shell Core Crosslinker concentration (CaCl2, mM) Size (nm) Polydispersity index Zeta potential (mV)
NLP-45KPa (w/o alginate) DOPC Saline 0 157± 55 0.247 −5.9± 3.6
NLG-1.6MPa DOPC Alginate 0 167± 40 0.205 −8.9± 2.2
NLG-5.3MPa DOPC Alginate 1 173± 42 0.272 −9.5± 1.2
NLG-13.8MPa DOPC Alginate 2.5 168± 38 0.164 −9.2± 1.1
NLG-19MPa DOPC Alginate 5 161± 39 0.226 −5.6± 2.5
The mean values and error bars are deﬁned as mean and S.D., respectively
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Fig. 2 Particle elasticity regulates in vitro cellular uptake. Relative cellular uptake of synthesized NLP and NLGs by MDA-MB-231 (a), MCF7 (b), and
MCF10A (c) cells. Relative cytotoxicity of engineered NLP and NLGs in MDA-MB-231 (d), MCF7 (e), and MCF10A (f) cells. The concentration (g) and
serum (h) dependence of particle elasticity-mediated cellular uptake in MDA-MB-231 cells. i Fluorescent microscope images of MDA-MB-231 cellular
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mean and S.D., respectively
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(Fig. 4a–c). This is due to NLP-45KPa entering cells predomi-
nantly via fusion, which is not affected by endocytosis inhibition
(Fig. 4d). In contrast, the internalization of NLG-19MPa was
signiﬁcantly inhibited by Chlorpromazine and Dynasore but not
Filipin (Fig. 4e). These results indicate that the internalization of
NLG-19MPa strictly depends on clathrin-mediated endocytosis.
This is also consistent in murine neoplastic 4T1 cells (Supple-
mentary Fig. 4). Particle elasticity modulates cellular uptake via
distinct cell internalization pathways.
Particle elasticity regulates in vivo tumor uptake. To determine
whether particle elasticity impacts tumor uptake and biodis-
tribution in vivo, near infrared (NIR) lipid dye, lipophilic car-
bocyanine DiIC18 (DiR)-labeled NLP-45KPa and NLG particles
were injected via the tail vein in an orthotopic, syngeneic, 4T1
breast tumor model. Tumor uptake was measured via NIR
ﬂuorescent imaging at 6 and 48 h post injection; the tumor
accumulation of NLP-45KPa and NLGs inversely correlated with
increasing particle elasticity, consistent with the in vitro cellular
uptake data. At 48 h, NLP-45KPa demonstrated the highest
tumor accumulation (Fig. 5a and b), exhibiting a 1.3, 1.9, and 2.6-
fold increase relative to NLG-1.6MPa, NLG-13.8MPa, and NLG-
19MPa, respectively. Particles with higher moduli were less likely
to accumulate into tumors.
The in vivo tumor uptake data obtained from live mice
precisely matched ex vivo NIR ﬂuorescent images of excised
tumors (Fig. 5c). Figure 5d shows the particle accumulation in six
organs (liver, spleen, lung, kidney, brain, and heart) and 4T1
tumors harvested from mice at 48 h after a single tail vein
administration. Of the six organs analyzed, the liver and spleen
were the major accumulation sites of all particles. Notably, the
liver uptake of NLGs with Young’s moduli above 13.8 MPa is
relatively higher than that of NLP-45KPa and NLG-1.6MPa
(Fig. 5d; Supplementary Fig. 5). Tumor uptake was signiﬁcantly
increased in NLP-45KPa and NLG-1.6MPa, suggesting that
decreasing elastic modulus preferentially enhances both cellular
internalization and permeation of tumors.
We further investigated the mouse immune system interaction
with NLP-45KPa and NLGs as a function of modulus by
measuring mouse leukocyte uptake of NLP-45KPa and NLGs.
Mouse blood was collected at 48 h post injection of DiR-labeled
NLP-45KPa or NLGs, and leukocytes were isolated from the
blood by red blood cell lysis and centrifugation. Leukocyte uptake
was quantiﬁed using ﬂow cytometry (Fig. 5e); no signiﬁcant
difference between different treatment groups was observed. This
is most likely due to particles being internalized by leukocytes via
non-speciﬁc phagocytosis27. To our knowledge, the in vivo data
presented here is the ﬁrst experimental evidence of particle
moduli regulating in vivo particle uptake within orthotopic
tumors.
Discussion
We synthesized a hybrid NLP-hydrogel vehicle that allows one to
alter particle modulus independently of particle size, shape, and
surface chemistry. The particle moduli varied from 45± 9 kPa to
19± 5MPa, which corresponded to up to a ﬁvefold in vitro cel-
lular uptake and 2.6-fold in vivo tumor uptake. The underlying
mechanism of the modulus-mediating cellular response is due to
an internalization pathway shift from fusion (low-energy
dependence) to endocytosis (high-energy dependence). This cell
internalization pathway shift can be switched by altering particle
elasticity.
Other mechanisms may also contribute to the particle
elasticity-mediated tumor uptake, such as the extravasation cap-
ability28,29. We therefore investigated the extravasation capability
of synthesized NLGs with tunable elasticity via a nanoporous
membrane deformability assay29 (Supplementary Fig. 6) and an
endothelial barrier assay28 (Supplementary Fig. 7). The difference
in extravasation between NLP-45KPa and NLGs is moderate
(~15%), not as dramatic as their cellular uptake differences
(~80%). We postulate that particle elasticity-mediated cell
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Fig. 3 Cell internalization pathway shift by varying particle elasticity. Soft NLP-45KPa (a) enters the cell via two pathways: fusion (predominant) and
endocytosis (inferior). Hard NLG-19MPa (b) enters cell via only clathrin-mediated endocytosis
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internalization pathway is the dominant mechanism for regulat-
ing in vivo tumor uptake. It is noteworthy that Jiang and Shi et al.
have systematically investigated the elasticity-mediated cell and
tumor uptake of lipid-coated poly(lactic-co-glycolic) acid (PLGA)
NPs, and they reported that rigid lipid-coated PLGA NPs enter
cell more efﬁciently than soft ones18,19. This is potentially due to
the fact that their lipid-coated PLGA NPs are signiﬁcantly more
rigid (Young’s modulus range: 0.76–1.20 GPa) than the NLP-
45KPa and NLGs tested in our studies (Young’s modulus range:
0.045–19MPa), and at such high elasticity, clathrin-mediated
endocytosis becomes the dominant cell internalization pathway
for both rigid and soft lipid-coated PLGA NPs, while fusion
pathway is negligible for these particles18. It suggests that the
important role of fusion pathway in particle elasticity-mediated
cell internalization is limited to a low particle elasticity (<19
MPa), and cannot be applied to highly elastic NPs (higher than
0.76 GPa).
From a broader perspective, our ﬁndings that particle modulus
regulates cell internalization pathways may have other important
implications. Most recently, the CRISPR–Cas9 system has
emerged as a revolutionary gene editing tool with tremendous
potential in genetic disease therapy30–32. However, like other
gene-based therapeutics (e.g., siRNA and plasmid), the utility of
CRISPR–Cas9 is limited by its rapid biodegradation and inefﬁ-
cient systemic delivery33–35. From a practical point of view, our
ﬁndings that NLPs fuse with the cell membrane and avoid
endosomes create an opportunity for intracellular delivery.
NLPs may mimic nature’s method for drug delivery. Extra-
cellular vesicles (e.g., exosomes), a naturally occurring drug
delivery system, with similar size and structure to our engineered
soft NLPs, provide efﬁcient delivery of proteins and RNAs to
facilitate intercellular communication in a range of diverse and
yet unknown cellular processes36–38. We can deduce that extra-
cellular vesicles may take advantage of low particle moduli to
protect their contents from endosome/lysosome degradation39,40.
In conclusion, particle modulus directly regulates cellular
uptake of drug delivery vehicles via regulating cell internalization
pathways. Our in vivo results also provide strong evidence that
particle elasticity governs tumor uptake of systemically adminis-
tered NPs. Taken together, our ﬁndings provide critical insight
into the role of biomechanical cues between particles and cells
and between particles and organs. This work may assist in the
design of more efﬁcient particles for therapeutic and diagnostic
applications.
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Methods
Cell culture. Human breast cancer MDA-MB-231 and MCF7 cells, human non-
neoplastic mammary epithelial MCF10A cells, murine breast cancer 4T1 cells, and
human microvascular endothelial cells (HMVECs) were purchased from American
Type Culture Collection (ATCC, Manassas, VA, USA). MDA-MB-231 and MCF7
cells were cultured in DMEM, 4T1 cells in RPMI-1640 Medium, MCF10A cells in
DMEM/F12 (1:1), and HMVECs in Lonza EGM-2-MV with recommended sup-
plements, respectively. All cells were cultured in a 37 °C humidiﬁed incubator with
5% CO2.
Preparation of NLP and NLGs. NLP and NLGs were prepared using extrusion
method with modiﬁcations20–22. Overall, 50 μmol 1,2-dioleoyl-sn-glycero-3-phos-
phocholine (DOPC) was dried under a stream of nitrogen gas and stored in a
vacuum desiccator overnight, the resulting phospholipid ﬁlm was resuspended in 1
mL DMSO:EtOH (7:3, v:v). This solution was added dropwise through a syringe
(gauge size 20) to a solution of 9 mL PBS or 1 mg/mL sodium alginate aqueous
solution under vigorous stirring. The resulting lipogel NP solution went through
ﬁve freeze-thaw cycles and was repetitively extruded through a 200 nm poly-
carbonate track etch nanoporous membrane for ﬁve times. The resulting NLP or
NLG solution was dialyzed in FLOAT-A-LYZER G2 dialysis tubing (MWCO 1,000
kDa) in deionized H2O overnight at 4 °C. After dialysis, an ionic crosslinking
solution containing (0–10 mM CaCl2) was added dropwise to NLG solution (1:1, v:
v) in order to crosslink the sodium alginate monomers within the liposomal
membrane. After 1 h incubation, the resulting NLG solution was further dialyzed in
FLOAT-A-LYZER G2 dialysis tubing (MWCO 1000 kDa) in PBS for 24 h at 4 °C.
In drug encapsulation experiments, FITC-dextran and siRNA-encapsulating NLP
and NLGs were prepared using the similar procedure except adding 1 mg/mL
FITC-dextran or 15 μg/mL siRNA to the 9 mL PBS or alginate solution. In the
cellular and tumor uptake experiments, OG488-DHPE or DiR-labeled NLP and
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Fig. 5 Particle elasticity regulates in vivo tumor uptake. a In vivo NIR ﬂuorescent images of mice at post-6h and -48h after i.v. administration of DiR-labeled
NLP-45KPa, NLG-1.6MPa, NLG-13.8MPa, and NLG-19MPa (n= 10 for each group). b In vivo tumor accumulation of synthesized NLP-45KPa and NLGs was
quantiﬁed by ﬂuorescent intensity. c Ex vivo NIR ﬂuorescent images of excised tumors at post 48 h. d The biodistribution of NLP-45KPa and NLGs in
organs (liver, spleen, lung, kidney, heart, and brain) and tumors was quantiﬁed by their ﬂuorescent intensity at post-48h (n= 10 for each group). e Uptake
of NLP-45KPa and NLGs by mouse leukocytes was quantiﬁed by ﬂow cytometry (n= 8–10 for each group). ns not signiﬁcant, *P< 0.05, **P< 0.01, ***P<
0.001. The mean values and error bars are deﬁned as mean and S.D., respectively
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NLGs were prepared using the similar procedure except adding 0.2 mol% OG488-
DHPE or 1 mol% DiR to 1 mL lipid solution.
In vitro cytotoxicity assay. The in vitro cytotoxicity of NLP and NLGs with
different elasticity was evaluated with human neoplastic and non-neoplastic cells41.
Brieﬂy, 104 cells (MDA-MB-231, MCF7, or MCF10A) were seeded in each well of a
96-well plate and incubated for 24 h. Cells were treated with NLP or NLGs with
different elasticity at 108 particles/mL in DMEM with 10% FBS for another 24 h.
Cells were rinsed twice with PBS and further grown for 48 h. The cell viability was
determined by a Dojindo cell viability assay using the protocol from the manu-
facturer (Rockville, MD, USA).
In vitro cellular uptake measurement. Overall, 10,000 cells (MDA-MB-231,
MCF7, or MCF10A) were seeded in each well of a 96-well plate and allowed to
attach overnight. To determine the cellular uptake of NLP and NLGs with different
elasticity, the cells were incubated with OG488 DHPE-labeled NLPs or NLGs at a
concentration of 108 particles/mL in DMEM with 10% FBS for 4 h. Cells were then
washed with PBS twice and the ﬂuorescence of each well on the 96-well plate was
quantiﬁed by SpectraMaxGEMIN XPS ﬂuorescence spectrophotometer (Molecular
Devices Corp, Sunnyvale, CA, USA) at 501/526 nm excitation/emission.
Orthotopic tumor model. Animal experiments were performed according to the
protocols approved by the Institutional Animal Care and Use Committees of City
College of New York. A total of 1 × 106 mouse breast cancer 4T1 cells were
orthotopically injected into the fourth mammary fat pad of female BALB/c mice (n
= 40, Charles River, Wilmington, MA, USA)42. For in vivo NIR ﬂuorescent imaging
experiments, tumors grew for 2–3 weeks until they were at least 200 mm3 in
volume. Mice were randomized into four treatment groups (n = 10 for each group),
which were injected i.v. with (1) DiR-NLP-45KPa, (2) DiR-NLG-1.6MPa, (3) DiR-
NLG-13.8MPa, (4) DiR-NLG-19MPa (at dosage of 20 mg lipids/kg mouse weight).
At 6 h and 48 h after the injection, in vivo ﬂuorescence imaging was performed on
tumor-bearing mice using an IVIS Lumina II system (Caliper, Hopkinton, MA,
USA). At 48 h post injection, the mice were sacriﬁced via cervical dislocation and
blood was collected immediately via cardiac puncture. The NIR ﬂuorescence
intensity of various excised organs (brain, heart, liver, lung, kidney, spleen, and
tumor) was measured by IVIS Lumina II system. The mouse leukocytes were
isolated from mouse whole blood via centrifugation at 1200 rpm for 15 min, and
followed by removing mouse red blood cells using RBC lysis buffer. The ﬂuores-
cence intensity of leukocytes treated with different DiR-labeled NLP and NLGs
were quantiﬁed using a BD FACSCalibur Flow Cytometer (BD Biosciences, San
Jose, CA, USA).
Statistical analysis. All of the experimental data were obtained in triplicate unless
otherwise mentioned and are presented as mean± S.D. Statistical comparison by
analysis of variance was performed at a signiﬁcance level of P< 0.05 based on a
Student’s t-test.
Data availability. The data that support the ﬁndings reported herein are available
on reasonable request from the corresponding authors.
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